T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders

NCT00176826 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

22

Enrollment

OTHER

Sponsor class

Stopped Replaced by another protocol

Conditions

Hemophagocytic Lymphohistiocytosis
X-Linked Lymphoproliferative Disorders
Chediak-Higashi Syndrome
Griscelli Syndrome
Immunologic Diseases
Langerhans-Cell Histiocytosis
Hematologic Diseases

Interventions

PROCEDURE: Stem Cell Transplant
DRUG: Myeloablative conditioning regimen

Sponsor

Masonic Cancer Center, University of Minnesota